Globe Life Inc. GL
Verdict: Hold. Fair value $180 against a price of $141 on 6 Jan 2026, 28% above the price.
In plain words
The case for: Narrow competitive moat provides durability.
The case against: Intense competitive pressure could compress margins. The OCF / Net Income ratio, while strong, has consistently declined from 1.59 in 2022 to 1.53 in....
Main risks
- Stagnant Free Cash Flow: TTM FCF of $1.25B is lower than in any of the past four full years, despite rising revenue and net income, indicating a potential deterioration in cash conversion.
- Questionable Capital Allocation Efficiency: The estimated 3-year ROIIC is approximately 5.4%, which is below the 10% threshold for good capital allocation and suggests that incremental investments are generating weak returns.
- Potential Margin Pressure: Free Cash Flow as a percentage of revenue has declined from ~27% in 2021 to ~21% on a TTM basis, signaling that top-line growth is not translating as effectively to cash flow.
- Intense competitive environment
- Sentiment trend deteriorating